105 related articles for article (PubMed ID: 6918183)
1. Modulation of the formation of the human C-3 amplification convertase of complement by polyelectrolytes.
Kazatchkine MD; Maillet F; Fischer E; Glotz D
Agents Actions; 1981 Dec; 11(6-7):645-6. PubMed ID: 6918183
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the formation of the human amplification C3 convertase of complement by polycations.
Maillet F; Kazatchkine MD
Immunology; 1983 Sep; 50(1):27-33. PubMed ID: 6554235
[TBL] [Abstract][Full Text] [Related]
3. Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b.
Maillet F; Kazatchkine MD; Glotz D; Fischer E; Rowe M
Mol Immunol; 1983 Dec; 20(12):1401-4. PubMed ID: 6558419
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.
Weiler JM; Yurt RW; Fearon DT; Austen KF
J Exp Med; 1978 Feb; 147(2):409-21. PubMed ID: 624904
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
Weiler JM; Gleich GJ
J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
[TBL] [Abstract][Full Text] [Related]
6. Polyions regulate the alternative amplification pathway of complement.
Weiler JM
Immunopharmacology; 1983 Oct; 6(3):245-55. PubMed ID: 6629739
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
8. Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.
Kazatchkine MD; Fearon DT; Metcalfe DD; Rosenberg RD; Austen KF
J Clin Invest; 1981 Jan; 67(1):223-8. PubMed ID: 6778897
[TBL] [Abstract][Full Text] [Related]
9. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
Waldo FB; Forristal J; Beischel L; West CD
J Clin Invest; 1985 Jun; 75(6):1786-95. PubMed ID: 3159752
[TBL] [Abstract][Full Text] [Related]
10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
11. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
12. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
Pangburn MK; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
[TBL] [Abstract][Full Text] [Related]
13. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1982 Dec; 129(6):2603-7. PubMed ID: 6923908
[TBL] [Abstract][Full Text] [Related]
14. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
[TBL] [Abstract][Full Text] [Related]
16. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
17. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
Pangburn MK; Müller-Eberhard HJ
Biochem J; 1986 May; 235(3):723-30. PubMed ID: 3638964
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycan.
Wilson JG; Fearon DT; Stevens RL; Seno N; Austen KF
J Immunol; 1984 Jun; 132(6):3058-63. PubMed ID: 6427331
[TBL] [Abstract][Full Text] [Related]
19. The C3/C5 convertase of the alternative pathway of complement: stabilization and restriction of control by lanthanide ions.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1983 Mar; 20(3):309-15. PubMed ID: 6553181
[TBL] [Abstract][Full Text] [Related]
20. C3 convertase of the human alternative pathway of complement: modulation of enzyme activity and stability by mouse monoclonal antibodies to Bb.
Fishelson Z; Müller-Eberhard HJ
Eur J Immunol; 1987 Feb; 17(2):303-4. PubMed ID: 3644748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
